These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17323614)

  • 1. [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
    Zeman M; Vecka M; Stopka P; Zahin M; Tvrzická E; Stanková B; Vareka T; Janíková L; Zák A
    Cas Lek Cesk; 2006; 145(12):923-8. PubMed ID: 17323614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
    Malik J; Melenovsky V; Wichterle D; Haas T; Simek J; Ceska R; Hradec J
    Cardiovasc Res; 2001 Nov; 52(2):290-8. PubMed ID: 11684077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients.
    Costet P; Hoffmann MM; Cariou B; Guyomarc'h Delasalle B; Konrad T; Winkler K
    Atherosclerosis; 2010 Sep; 212(1):246-51. PubMed ID: 20619837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study.
    Ghayour-Mobarhan M; Lamb DJ; Vaidya N; Livingstone C; Wang T; Ferns GA
    Angiology; 2005; 56(1):61-8. PubMed ID: 15678257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
    Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A relationship between insulin resistance and reduction in oxidative stress in vivo by atorvastatin].
    Hitsumoto T; Iizuka T; Takahashi M; Nakamura K; Shimizu K; Satoh S; Sugiyama Y; Sakurai T; Noike H; Ohsawa H; Watanabe H; Shirai K
    J Cardiol; 2004 Dec; 44(6):233-42. PubMed ID: 15638221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
    Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
    J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ; Hammervold T; Rustan AC; Howe PR
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia.
    Sebestjen M; Zegura B; Keber I
    J Intern Med; 2002 Jan; 251(1):77-85. PubMed ID: 11851868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K; Weltzien P; Friedrich I; Schmitz H; Nickell HH; Hauck P; Hoffmann MM; Baumstark MW; Wieland H; März W
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):241-7. PubMed ID: 15146369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
    Amudha K; Choy AM; Mustafa MR; Lang CC
    Cardiovasc Ther; 2008; 26(4):253-61. PubMed ID: 19035876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK; Watts GF; Chan DC; Stanton K
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM
    J Diabetes Complications; 2014; 28(3):323-7. PubMed ID: 24560135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects.
    Marketou ME; Zacharis EA; Nikitovic D; Ganotakis ES; Parthenakis FI; Maliaraki N; Vardas PE
    Angiology; 2006; 57(2):211-8. PubMed ID: 16518530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential associations of statin and fibrate treatment with carotid arterial remodeling.
    Chironi G; Simon A; Gariepy J; Balice M; Del-Pino M; Levenson J
    Am J Hypertens; 2005 Nov; 18(11):1476-81. PubMed ID: 16280285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
    Kei A; Tellis C; Liberopoulos E; Tselepis A; Elisaf M
    Cardiovasc Ther; 2014 Aug; 32(4):139-46. PubMed ID: 24618208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.